The novel CXCR4 antagonist POL5551 mobilizes hematopoietic stem and progenitor cells with greater efficiency than Plerixafor
新型 CXCR4 拮抗剂 POL5551 比 Plerixafor 更有效地动员造血干细胞和祖细胞
期刊:Leukemia
影响因子:12.8
doi:10.1038/leu.2013.266
D Karpova, K Dauber, G Spohn, D Chudziak, E Wiercinska, M Schulz, A R Pettit, J P Levesque, B Romagnoli, K Patel, E Chevalier, K Dembowsky, H Bonig
